Close Menu

NEW YORK (360Dx) – Thermo Fisher Scientific said today that Health Canada has granted a Class III Medical Device System License to its BRAHMS business for four automated immunofluorescent assays to be used as aids in prenatal screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.